Pelthos Therapeutics Inc.
PTHS· NYSE
Released Aug 13, 2024, after the close
10-Q filed Aug 13, 2024, 44 days after period end · 0001753926-24-001423
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2024 | Q2 2023 |
|---|---|---|
| Net Income | -$1.77M | -$953.35K |
| EPS Diluted | -$3.07 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pelthos Therapeutics Inc. · CIK 1919246 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 13, 2024 · 44 d after period end